CDH1 and esophageal cancer: Paclitaxel combined with luteolin could inhibit the proliferation and migration, promote apoptosis of human esophageal cancer cell lines EC109 and TE-1, which was attributed to expression changes of EMT-related proteins, down-regulation of N-Cadherin, β-Catenin and Vimentin, and up-regulation of E-Cadherin, Claudin-1 and ZO-1 (47).